Mitsubishi UFJ Asset Management Co. Ltd. Grows Position in The Cooper Companies, Inc. (NASDAQ:COO)

Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 306,992 shares of the medical device company's stock after purchasing an additional 10,428 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.15% of Cooper Companies worth $28,179,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 56.4% during the 3rd quarter. Cerity Partners LLC now owns 19,179 shares of the medical device company's stock valued at $2,116,000 after purchasing an additional 6,916 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Cooper Companies by 28.5% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 45,261 shares of the medical device company's stock valued at $4,994,000 after buying an additional 10,045 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in Cooper Companies by 11.9% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock valued at $200,665,000 after buying an additional 194,118 shares in the last quarter. Public Sector Pension Investment Board raised its position in shares of Cooper Companies by 14.5% in the third quarter. Public Sector Pension Investment Board now owns 8,690 shares of the medical device company's stock worth $959,000 after acquiring an additional 1,100 shares during the period. Finally, Captrust Financial Advisors boosted its stake in shares of Cooper Companies by 9.7% during the 3rd quarter. Captrust Financial Advisors now owns 3,816 shares of the medical device company's stock worth $421,000 after acquiring an additional 338 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

COO has been the subject of several recent analyst reports. Piper Sandler restated an "overweight" rating and issued a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Stifel Nicolaus cut their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Morgan Stanley decreased their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Friday, December 6th. Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $110.25.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded down $4.40 on Friday, hitting $73.77. 2,661,526 shares of the company were exchanged, compared to its average volume of 1,365,871. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $87.76 and a 200 day moving average price of $96.33. The stock has a market capitalization of $14.75 billion, a price-to-earnings ratio of 37.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The Cooper Companies, Inc. has a 1-year low of $73.32 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.